| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/17/2011 | EP2355841A1 Immunization protocol for directed expansion and maturation |
| 08/17/2011 | EP2355840A2 Chemoattractants inhibitors and the use thereof |
| 08/17/2011 | EP2355798A1 Modified cationic liposome adjuvans |
| 08/17/2011 | EP2355797A1 Composition for targeting dendritic cells |
| 08/17/2011 | EP1962899B1 Pneumococcal polysaccharide conjugate vaccine |
| 08/17/2011 | EP1915151B1 Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors |
| 08/17/2011 | EP1731612B1 Recombinant herpesvirus and utilization of the same |
| 08/17/2011 | EP1678316B1 Campylobacter polypeptides and methods of use |
| 08/17/2011 | EP1608675B1 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 08/17/2011 | EP1590373B1 Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide |
| 08/17/2011 | EP1578936B1 Human anti-ifn-gamma neutralizing antibodies as selective ifn-gamma pathway inhibitors |
| 08/17/2011 | EP1575531B1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 08/17/2011 | EP1571970B1 Diagnosis and monitoring of diseases |
| 08/17/2011 | EP1562571B1 Combination of a diamide derivative and immunosuppressive agents for inhibiting transplant rejection |
| 08/17/2011 | EP1404841B1 Cyp1b1 nucleic acids and methods of use |
| 08/17/2011 | CN1681845B Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 08/17/2011 | CN102159705A Mutant pestivirus with mutations in core gene and ns3 region |
| 08/17/2011 | CN102159243A Structural variants of antibodies for improved therapeutic characteristics |
| 08/17/2011 | CN102159242A Vaccine adjuvant combinations |
| 08/17/2011 | CN102159241A Tapasin augmentation for enhanced immune response |
| 08/17/2011 | CN102159240A Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 08/17/2011 | CN102159239A Vaccine against HPV |
| 08/17/2011 | CN102159225A Non-typeable haemophilus influenzae vaccines and their uses |
| 08/17/2011 | CN102159219A Method of enhancing tgf-beta signalling |
| 08/17/2011 | CN102159204A Stable liquid antibody formulation |
| 08/17/2011 | CN102159194A Novel antibody formulation |
| 08/17/2011 | CN102154367A Swine influenza virus H3N2 and H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof |
| 08/17/2011 | CN102154366A Swine influenza virus H3N2 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof |
| 08/17/2011 | CN102154365A Swine influenza virus H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof |
| 08/17/2011 | CN102154348A Vibrio anguillarum and edwardsiella tarda-resistant multi-valence live vaccine, correlative expression vector and application |
| 08/17/2011 | CN102154325A Vaccine against human papillomavirus (HPV) as well as preparation method and application thereof |
| 08/17/2011 | CN102154324A Construction method of mycobacterium tuberculosis fusion protein Mtb 10.4-Hsp16.3, expression method thereof, purification method thereof and application thereof |
| 08/17/2011 | CN102154259A Preparation method and use of genetic engineering preparation for dissolving blood platelet thrombi |
| 08/17/2011 | CN102154229A EV71 virus-like particles and hand-foot-and-mouth disease vaccine prepared from EV71 virus-like particles |
| 08/17/2011 | CN102154223A Recombinant adenovirus with fusion protein gene and preparation method and application thereof |
| 08/17/2011 | CN102154220A Method and equipment for ultrahigh-density and large-scale production of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 08/17/2011 | CN102154219A Swine influenza A H1N1 virus and use thereof |
| 08/17/2011 | CN102154218A Hybridoma cell strain 4e9 and monoclonal antibody produced by using hybridoma cell strain 4e9 |
| 08/17/2011 | CN102154208A Preparation method and use of cord blood-derived (CD)133 and brain glioma stem cell antigen carrying dendritic cells |
| 08/17/2011 | CN102154184A Attenuated Salmonella pullorum and application thereof |
| 08/17/2011 | CN102154176A Turbot pathogenic strain and inactivated vaccine for ascites disease |
| 08/17/2011 | CN102153658A Tumor antigen, DC (dendritic cell) tumor vaccine and preparation method thereof |
| 08/17/2011 | CN102153656A Vaccine for chimeric virus-like particles and preparation method thereof |
| 08/17/2011 | CN102153654A Branched polypeptide using immune active peptide as vector and derivatives and application of branched polypeptide |
| 08/17/2011 | CN102153650A Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153649A Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof |
| 08/17/2011 | CN102153648A EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof |
| 08/17/2011 | CN102153647A Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153644A Antigenic peptide for dimerization of epidermal growth factor receptor |
| 08/17/2011 | CN102153632A Antibody of escherichia coli resistant TolC tricosanoic peptide and application |
| 08/17/2011 | CN102153621A B-cell epitope of NA-protein for new influenza A (H1N1) and application thereof |
| 08/17/2011 | CN102151334A Antibody against a tumor-specific antigen as target |
| 08/17/2011 | CN102151333A Vaccination against host cell-associated herpesviruses |
| 08/17/2011 | CN102151332A Helicobacter pylori epitope vaccine, design method thereof, preparation method thereof and application thereof |
| 08/17/2011 | CN102151331A Polysaccharide-protein conjugate vaccines |
| 08/17/2011 | CN102151330A Vaccine and method for treatment of motor neurone diseases |
| 08/17/2011 | CN101845419B Recombinant adenovirus and application thereof |
| 08/17/2011 | CN101703768B Preparation method of vibrio parahaemolyticus outer membrane protein VP1061 and application of immunity protective function thereof |
| 08/17/2011 | CN101690810B Tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu and preparation method thereof |
| 08/17/2011 | CN101411873B Dual inactivated bacterin for ascites disease of cultivated flounder and preparation method |
| 08/17/2011 | CN101348526B Anti-interleukin-8 antibody |
| 08/17/2011 | CN101332297B Preparation method of novel subunit vaccine of pig pseudorabies |
| 08/17/2011 | CN101107007B GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/17/2011 | CN101035559B Multivalent avian influenza vaccines |
| 08/16/2011 | US7999082 monoclonal antibodies or antigen-binding fragments used to reduce or prevent respiratory system hyperresponsiveness and/or inflammation; treatment of respiratory system disorders |
| 08/16/2011 | US7999081 Anti-C5 alpha antibodies |
| 08/16/2011 | US7999079 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 08/16/2011 | US7998960 Affinity adsorbents for plasminogen |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998701 Molecule |
| 08/16/2011 | US7998680 Determining genotype of a polymorphic site in the hereditary hemochromatosis gene |
| 08/16/2011 | US7998502 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 08/16/2011 | US7998492 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 08/16/2011 | US7998491 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 08/16/2011 | US7998490 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
| 08/16/2011 | US7998488 Vaccine formulations and uses thereof |
| 08/16/2011 | US7998487 Antitoxin and vaccine platform based on nodavirus VLPs |
| 08/16/2011 | US7998485 Sialoadhesin-related compositions and methods |
| 08/16/2011 | US7998484 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 08/16/2011 | US7998483 Lage-1 tumor associated nucleic acids |
| 08/16/2011 | US7998482 Methods and reagents for the analysis and purification of polysaccharides |
| 08/16/2011 | US7998481 Using C-type lectin-like activating receptor specific immunglobulin to treat and/or prevent hepatitis viral infection |
| 08/16/2011 | US7998480 Human BNP immunospecific antibodies |
| 08/16/2011 | US7998479 Substance specific to human PD-1 |
| 08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
| 08/16/2011 | US7998477 Spherical protein particles and methods for making and using them |
| 08/16/2011 | US7998471 Mycobacteria expressing HIV-1 and malaria antigens |
| 08/16/2011 | US7998461 Salmonella cancer therapeutics and related therapeutic methods |
| 08/16/2011 | CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 08/16/2011 | CA2456648C Human antibodies specific for interleukin 15 (il-15) |
| 08/16/2011 | CA2411925C Immunization of dairy cattle with mig protein |
| 08/16/2011 | CA2389979C Methods of inhibiting metastasis |
| 08/16/2011 | CA2376164C Intermolecularly associating compounds, and aggregates comprising them |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/11/2011 | WO2011097627A1 Antibody drug conjugates (adc) that bind to 161p2f10b proteins |
| 08/11/2011 | WO2011097573A2 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells |
| 08/11/2011 | WO2011097527A2 Immunoprotection of therapeutic moieties using enhanced fc regions |
| 08/11/2011 | WO2011097513A1 Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor |
| 08/11/2011 | WO2011097500A2 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 08/11/2011 | WO2011097477A1 Icos critically regulates the expansion and function of inflammatory human th17 cells |